Summary

Summary

Contract Unique IdentifierDO1.SLCNTR.543603 
Contract referenceInst. Nac. de Cancer-2021-00146 
Contract description:MEDICAMENTOS 
Services 
Contract Start:
02/08/2021 10:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End:
06/12/2021 08:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Legally Binding?
 
Contract StateAccepted 

Contracting Company Identification

Contracting Company Identification


Supplier Company Identification

Supplier Company Identification



Object Info

Object Info

DGCP-08-ProcesosExcepcion 
Inst. Nac. de Cancer-CCC-PEEX-2021-0002 
MEDICAMENTOS  
MEDICAMENTOS  
LOGISTICA 
101003383_EXT_CP001 
ServicesDominicana 
23,498,790 Dominican Pesos 

Financial & Delivery Conditions

Financial & Delivery Conditions

Delivery optionsTransporte incluido 
Contract Start Date
02/08/2021 10:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End Date
06/09/2021 08:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
nstituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavares Av. Correa y Cidrón, Esq. Rafael A. Sánchez Ravelo, Zona Universitaria DO 

Payment Conditions

Payment Conditions

Payment Method 
Invoice Payment Deadline60 days 

Contract Comments

Contract Comments

REQ. AM0399-2020 / AM041-2020 / AM0402-2020 / JACQUELINE RODRIGUEZ

 
 
 1 
DO1.PCCNTR.1083432 ContractData Container
 1.1  
-
    
Total sin descuentosValor del descuentoTotal ITBISTotal Otros ImpuestosSubtotalTotal
23,498,790.000.000.000.0023,498,790.0023,498,790.00
    
ReferenciaCódigo UNSPSCCuenta presupuestariaDescripciónCantidadUnidadPrecio unitario estimadoPrecio unitarioImporte moneda orig. s/ITBIS% Desc.Descuento moneda originalMonto Gravado (Obras)% ITBISITBIS Moneda Original% Otros ImpuestosOtros impuestos moneda originalPrecio total estimadoValor del precio de respuesta
    
1
51111713 - Alemtuzumab
2.3.4.1.01BEVACIZUMAB 100 MG INY AVASTIN60UD28,69028,6901,721,400.000.000.000.001,721,400.001,721,400.00
    
2
51111713 - Alemtuzumab
2.3.4.1.01BEVACIZUMAB 400 MG INY AVASTIN45UD114,758114,7585,164,110.000.000.000.005,164,110.005,164,110.00
    
4
51111716 - Rituximab
2.3.4.1.01MABTHERA 500 MG15UD67,20067,2001,008,000.000.000.000.001,008,000.001,008,000.00
    
5
51111716 - Rituximab
2.3.4.1.01MABTHERA 100 MG / 10 ML30UD13,50013,500405,000.000.000.000.00405,000.00405,000.00
    
6
51111716 - Rituximab
2.3.4.1.01MABTHERA 1400 MG/11.7 ML15UD78,40078,4001,176,000.000.000.000.001,176,000.001,176,000.00
    
7
51111717 - Trastuzumab
2.3.4.1.01TRASTUZUMAB 600 MG/ 5 ML VIAL60UD107,908107,9086,474,480.000.000.000.006,474,480.006,474,480.00
    
8
51111616 - Capecitabina
2.3.4.1.01CAPECITABINA 500 MG TABL ( XELODA)18,000UD1801803,240,000.000.000.000.003,240,000.003,240,000.00
    
9
51131506 - Eritropoyetina
2.3.4.1.01ERITROPOYETINA 30,000 UI INY90UD7,6007,600684,000.000.000.000.00684,000.00684,000.00
    
11
51111717 - Trastuzumab
2.3.4.1.01CETUXIMAB 5 MG /20 MG AMP (ERBITUX)120UD30,21530,2153,625,800.000.000.000.003,625,800.003,625,800.00
 
Contract Document Template

Contract Document Template

DescriptionFile Name
Download
Download
Download
Download

Budget Settings

Budget Settings

Investment
General Source
16,700,202.00 DOP
 DOP
AccountValueAnnual Availability
2.3.4.1.0116,700,202.00  DOP----View
Payment Calendar
IDDescriptionValueMonthYear
1  116,700,202.00  DOPAbril2021
Certificate of Appropriation
YearCertificate CodeCertificate VersionCertificate ValueCertificate StateCertificate Link
20211116,700,202.00  DOP